Fingerprint
Dive into the research topics of 'Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real-world data'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real-world data
Mudi Misgav, Tami Brutman-Barazani, Ivan Budnik, Einat Avishai, Jonathan Schapiro, Dalia Bashari, Assaf A. Barg, Aaron Lubetsky, Tami Livnat, Gili Kenet
Research output: Contribution to journal › Article › peer-review
26
Scopus
citations